Press & News

MedGenome presented a poster on its study of potential cancer vaccines for Lynch Syndrome patients SAN FRANCISCO, CALIFORNIA, UNITED STATES, February 24, 2018 /EINPresswire.com/ — Attendees at the 2018 Molecular Medicine Tri-Conference heard MedGenome, a global leader in genomics research and a partner to pharma/biotech companies and academic research institutions conducting complex disease biomarker-identification projects, […]

FOSTER CITY, Calif., Jan. 31, 2018 /PRNewswire/ — MedGenome has expanded its sequencing capacity at its Foster City, Calif., headquarters laboratory, adding HiSeqX and NovaSeq 6000 platforms to meet the rising demands for Next Generation Sequencing (NGS) in research and clinical settings. The new additions increase MedGenome’s data-generation capability by a factor of five. Additionally,

Genomics research and diagnostics company aims to accelerate biomarker discovery by leveraging the genetic diversity of the Indian population FOSTER CITY, Calif., Aug. 28, 2017 /PRNewswire/ — MedGenome, a leading genomics research and diagnostics company, announced completion of $30 million in Series C financing led by Sequoia India and Sofina s.a., with participation by Zodius

The poster will be presented at ‘Frontiers in Cancer Immunotherapy’ conference in New York FOSTER CITY, CA, UNITED STATES, February 8, 2017 /EINPresswire.com/ — MedGenome will present a poster titled “Tumor microenvironment analysis provides insights into the activity of CD8 T-cells and their impact on survival.” at the Frontiers in Cancer Immunotherapy conference organized by

Key appointment to strengthen company’s expansion efforts FOSTER CITY, CA, UNITED STATES, January 9, 2017 /EINPresswire.com/ — MedGenome, a genomics-driven research and diagnostics company based in Foster City, California, today announced the appointment of Michael A. Nemzek as its Chief Commercial Officer. Mr. Nemzek has held executive senior leadership team positions in both public companies

The analysis compares the immune microenvironment of uveal melanoma and skin cutaneous melanoma FOSTER CITY, CALIFORNIA, UNITED STATES, July 21, 2016 /EINPresswire.com/ — MedGenome will be presenting its analysis comparing the immune microenvironment of uveal melanoma and skin cutaneous melanoma at the Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, September 25-28, 2016, New York. The remarkable

ZellNet will be a distributor for MedGenome’s OncoPept™ – a powerful end to end genomics platform to accelerate immune-oncology research. FOSTER CITY, CA, UNITED STATES, June 4, 2016 /EINPresswire.com/ — MedGenome announced a strategic partnership with ZellNet Consulting – a trusted provider of immune monitoring services for over 18 years. This arrangement seamlessly integrates MedGenome’s

FOSTER CITY, California, May 6, 2016 /PRNewswire/ — MedGenome will present its abstract titled ‘SAGVDB – An integrated resource for South Asian genome variation’ at the Big Data Bioinformatics Conference, to be held on May 26th-27th 2016 in Boston, MA. A deep understanding of human genetic variation is essential for investigating the relationship between genotype

OncoPeptTOPE™ is freely accessible online to DNA / Peptide vaccine researchers FOSTER CITY, CA, UNITED STATES, April 29, 2016 /EINPresswire.com/ — MedGenome recently announced that its proprietary OncoPeptTOPE™ database of neo-antigens and neo-epitopes derived from genetic alterations using TCGA data will be made freely accessible to researchers in the cancer immunotherapy space. The database captures

FOSTER CITY, CA, UNITED STATES, April 12, 2016 /EINPresswire.com/ — MedGenome will present results from its analysis of the whole genome sequence data from the Wellderly study (Scripps Translational Science Institute) at the Diabetes Summit 2016, from April 25-27th in Boston, MA. The study titled “Whole Genome Sequencing data from the Wellderley study identifies rare